Věra Adámková

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA

Renata Cífková, Zdenka Škodová, Jan Bruthans et al. · Atherosclerosis · 2010 · 143 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Disease Risk Assessment +12

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

The influence of <i>APOAV</i> polymorphisms (T‐1131&gt;C and S19&gt;W) on plasma triglyceride levels and risk of myocardial infarction

Jaroslav A. Hubáček, Z Škodová, Věra Adámková et al. · Clinical Genetics · 2004 · 102 citations

Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008

Renata Cífková, Zdenka Škodová, Jan Bruthans et al. · Journal of Hypertension · 2010 · 79 citations